A series of amphiphilic polyisobutylene-b-poly (2-ethyl-2-oxazoline) (PIB-b-PEOX) diblock copolymer/Ag nanoparticle composites were successfully in-situ synthesized via cationic ring-opening polymerization of 2-ethyl-2-oxazoline (EOX) with high initiation efficiency by using allyl bromide end functionalized polyisobutylene (PIB-allylBr) as a macroinitiator and AgClO4 as a coinitiator. The microphase separation formed in the resulting PIB-b-PEOX diblock copolymers due to the thermodynamic imcompability of hydrophilic PEOX segments and hydrophobic PIB segments. The micromorphology of phase separation is dependent on the copolymer composition, in which sea-island micromorphology formed for PIB118-b-PEOX80 and bicontinuous phase micromorphology formed for PIB118-b-PEOX97. The micelles with nano-scale size in the range of 15–80 nm and having high drug loading rate of ca. 48.9 % can be formed by self-assembly of the amphiphilic diblock copolymers in n-hexane. The drug cumulative release rate can be increased with an increase in the proportion of PEOX segments, due to the strong interaction between ibuprofen and the PEOX segments. The hydrophilicity of the PIB-b-PEOX diblock copolymer surfaces can be improved after ethanol vapor induction. The PIB-b-PEOX diblock copolymers behave biocompatibility and good anti-protein adsorption property. The amphiphilic PIB-b-PEOX diblock copolymer/Ag nanoparticle composites exhibit high antibacterial efficiency for Gram-negative bacterium (E. coli) and Gram-positive bacterium (S. aureus). To the best of our knowledge, this is the first example of PIB-b-PEOX diblock copolymer/Ag nanoparticle (6.4 ± 2.6 nm) composites synthesized in-situ with good biocompatibility, anti-protein adsorption, and antibacterial properties, which would have potential applications for drug delivery and anti-protein coating in biomedical areas.
Read full abstract